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The oxalato complexes [Ru2(m-h4-C2O4)Cl2(h6-p-PriC6H4Me)2] 1 and [Ru(h2-C2O4)(NH3)(h6-p-PriC6H4Me)] 2
have been prepared from the reaction of ammonium oxalate with [{RuCl2(h6-p-PriC6H4Me)}2] and [Ru(H2O)3-
(h6-p-PriC6H4Me)]21, respectively. With triphenylphosphine, 1 reacted to give [Ru2(m-h4-C2O4)(PPh3)2(h6-p-PriC6-
H4Me)2]21 3, while 2 gave [Ru(h2-C2O4)(PPh3)(h6-p-PriC6H4Me)] 4. The dichloro complex 1 can also be converted
into the cationic dimethanol complex [Ru2(m-h4-C2O4)(MeOH)2(h6-p-PriC6H4Me)2]21 5 by precipitation of the
chloride with a silver salt in methanol. Complex 5 reacted with 4,49-bipyridine to afford a novel tetranuclear
metallomacrocycle [Ru4(m-h4-C2O4)2(m-h1 :h1-bipy)2(h6-p-PriC6H4Me)4]41 6 with alternating oxalato and 4,49-
bipyridine bridges. The reaction between 1 and azide yielded the known azido-bridged complex [{Ru(m-h1-N3)-
Cl(h6-p-PriC6H4Me)}2] 7. The molecular structures of 1 (two conformational isomers), 4, 5 and 6 have been solved
by X-ray crystallography.
Many organorhodium complexes containing bidentate oxygen
ligands such as b-diketonate,1 tropolonate (the anion of
2-hydroxycyclohepta-2,4,6-trienone),2 oxalate,3 chloranilate
(the dianion of 2,5-dichloro-3,6-dihydroxy-p-benzoquinone),4
squarate (3,4-dihydroxycyclobut-3-ene-1,2-dionate),5 pyronate
and pyridinonate 6 anions are known. In contrast, organo-
ruthenium complexes containing bidentate oxygen ligands have
not been extensively studied.7 Half-sandwich ruthenium com-
plexes containing oxalato ligands have not been reported so far.
It is well known that ruthenium complexes are versatile com-
pounds, able to catalyse various organic reactions.8.9 In recent
years there has been an increasing interest in mononuclear half-
sandwich ruthenium complexes containing a chloride ligand
and a chelating ligand, because the labile chloride can be readily
displaced by small molecules such as H2, N2, O2, CO, CO2 and
CH2]]CH2.
7b,10–19 The co-ordination of such molecules is inter-
esting with respect to activation for catalytic transformations.
Thus, a half-sandwich cationic complex [Ru(h5-C5Me5)-
{h1-PPh2CH2CHO(CH2)3O}{h
2-PPh2CH2CHO(CH2)3O}]1 was
found to catalyse the hydrogenation of hex-1-ene to n-hexane.18c
In this paper we report on mono-, di- and tetra-nuclear p-
cymeneruthenium complexes containing bidentate and bis-
bidentate oxalato ligands.
Results and Discussion
The p-cymene complex [{RuCl2(h6-p-PriC6H4Me)}2] reacts with
(NH4)2C2O4 in chloroform–methanol solution at 60 8C to give
the dinuclear complex [Ru2(m-h4-C2O4)Cl2(h6-p-PriC6H4Me)2] 1
(Scheme 1) as the only product. Complex 1 is soluble in CH2Cl2
and water. In the infrared spectrum it gives rise to only one very
strong absorption at 1614 cm21 for the C]]O stretching of the
oxalato ligand. The 13C NMR spectrum shows, apart from the
resonances of the p-cymene ligands, only one signal at d 171.2
for the oxalato ligand. Depending on the solvent, 1 crystallizes
in two quite different crystalline forms. The single-crystal X-ray
analysis shows two conformational isomers 1a (monoclinic
crystals from CHCl3) and 1b (orthorhombic crystals from
CHCl3–MeOH–Et2O) as represented in Fig. 1. No significant
differences in bond lengths and angles of the two structures are
observed (Table 1), even though 1b is the sterically less favour-
able conformer. However, as the orientation of the isopropyl
group of the p-cymene ligand is different with respect to the
chloride co-ordination, the torsion angles about bonds
Ru(1)]C(2) and Ru(1)]C(5) are quite different, see Table 1.
Compared to mononuclear half-sandwich ruthenium chloro
complexes (Ru]Cl bond length range: 2.42–2.47 Å),7,12–16,20 1a
and 1b have shorter Ru]Cl bond distances [2.394(1) Å in 1a and
2.391(1) Å in 1b].
The mononuclear oxalato complex [Ru(h2-C2O4)(NH3)-
(h6-p-PriC6H4Me)] 2 was prepared by the reaction of [Ru-
(H2O)3(h
6-p-PriC6H4Me)]21 with (NH4)2C2O4 in an aqueous
solution at pH 6–9 and 70 8C (Scheme 1). Complex 2 is also
soluble in both CH2Cl2 and water. The 
13C NMR spectrum
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which should be used for any reference to this work
1
shows one peak at d 167.9 revealing two equivalent C atoms of
the oxalato ligand. The infrared spectrum displays two different
C]]O absorptions at 1701 and 1665 cm21, corresponding to the
stretching vibrations of the C]]O bonds with co-ordinated and
free oxygen atoms of the oxalato ligand. The bands of a NH3
ligand and a H2O of crystallization appear in the 3177–3300
cm21 region. The presence of the NH3 ligand and the H2O mol-
ecule of crystallization is also confirmed by the microanalytical
data. The mass spectrum shows the molecular ion peak without
Fig. 1 View of the structures of [Ru2(m-h4-C2O4)Cl2(h6-p-PriC6H4Me)2]
1 with two conformational isomers 1a (a) and 1b (b)
Table 1 Selected bond lengths (Å) and angles (8) for compounds 1a
and 1b 
1a 
Ru(1)]Cl(1) 
Ru(1)]O(1) 
Ru(1)]O(2a) 
O(1)]C(1) 
O(2)]C(1) 
C(1)]C(1a) 
Ru ? ? ? Ru 
 
O(1)]Ru(1)]O(2a) 
C(1)]O(2)]Ru(1a) 
C(1)]O(1)]Ru(1) 
O(1)]C(1)]C(1a) 
O(2)]C(1)]C(1a) 
O(1)]C(1)]O(2) 
O(1)]Ru(1)]Cl(1) 
O(2a)]Ru(1)]Cl(1) 
 
 
2.3945(14) 
2.127(3) 
2.129(3) 
1.252(5) 
1.256(6) 
1.530(9) 
5.500(6) 
 
77.99(12) 
112.6(3) 
112.6(3) 
117.5(5) 
117.0(5) 
125.5(4) 
84.72(10) 
82.90(11) 
 
1b 
Ru(1)]Cl(1) 
Ru(1)]O(1) 
Ru(1)]O(2b) 
C(1)]O(1) 
C(1)]O(2) 
C(1)]C(1b) 
Ru ? ? ? Ru 
 
O(1)]Ru(1)]O(2b) 
C(1)]O(1)]Ru(1) 
C(1)]O(2)]Ru(1b) 
O(1)]C(1)]C(1b) 
O(2)]C(1)]C(1b) 
O(1)]C(1)]O(2) 
O(1)]Ru(1)]Cl(1) 
O(2b)]Ru(1)]Cl(1) 
 
 
2.3913(9) 
2.128(2) 
2.134(2) 
1.255(4) 
1.256(4) 
1.536(7) 
5.506(5) 
 
77.83(9) 
112.6(2) 
112.4(2) 
117.1(3) 
117.0(4) 
125.9(3) 
83.94(7) 
84.37(7) 
 
Torsion angles 1a 1b
Cl(1)]Ru(1)]C(2)]C(8)
Cl(1)]Ru(1)]C(5)]C(11)
103.3(5)
19.8(6)
34.3(4)
85.7(4) 
Symmetry operations: a 2x, 2y 1 1, 2z; b 2x, 2y, 2z. 
a water of crystallization. The spectroscopic and analytical
data are consistent with the formulation [Ru(h2-C2O4)-
(NH3)(h
6-p-PriC6H4Me)]?H2O, in which the NH3 ligand stems
from ammonium oxalate. Further evidence for the co-
ordination of NH3 rather than H2O comes from the following
experiment: replacing (NH4)2C2O4 by Na2C2O4 does not give 2.
The analogous complex [Ru(h2-C2O4)(H2O)(h6-p-PriC6H4Me)]
forms presumably, but the co-ordination of the H2O is too weak
for isolation of the complex. In addition, it is noteworthy that
in aqueous solution the oxalate group does not link two (h6-p-
PriC6H4Me)Ru units to form a dinuclear complex.
Chloride abstraction from complex 1 with equal amounts of
PPh3 in the presence of Na[O3SCF3] leads to formation of the
complex [Ru2(m-h4-C2O4)(PPh3)2(h6-p-PriC6H4Me)2]21 3 as the
only product (Scheme 1). The 31P NMR spectrum of 3 shows
only one peak at d 32.1, the IR spectrum displays one strong
absorption at 1626 cm21 indicating the presence of the
symmetrical oxalato ligand. In the mass spectrum two strong
characteristic fragments [Ru(PPh3)(h6-p-PriC6H4Me)]1 and
[Ru(PPh3)]1 can be observed. The constitution of 3 is proposed
on the basis of the microanalytical and spectroscopic data.
The mononuclear complex [Ru(h2-C2O4)(PPh3)(h6-p-PriC6-
H4Me)] 4 was prepared from 2 by substitution of NH3 with
PPh3 (Scheme 1). In the IR spectrum of 4 two absorptions at
1694 and 1672 cm21 indicate two inequivalent C]]O stretching
vibrations of the oxalato ligand. In the 31P NMR spectrum only
one resonance was found at d 30.4, while in the mass spectrum
the molecular ion peak was observed. The molecular structure
of 4 was solved by a single-crystal X-ray analysis and is shown
in Fig. 2, with selected bond lengths and angles listed in Table 2.
The Ru]P bond length [2.367(2) Å] in 4 is comparable to that
found in related Ru]PPh3 complexes.
14b,21 The oxalate is co-
ordinated by two vicinal oxygen atoms giving rise to the form-
ation of a five-membered metallacycle. The C]O distances of
the co-ordinated oxygen atoms [C(11)]O(1) 1.330(6), C(12)]
O(2) 1.271(6) Å] are as expected longer than those of the non-
co-ordinated oxygen atoms [C(11)]O(4) 1.221(7), C(12)]O(3)
1.226(6) Å]. The O]C]C angles of the oxalato ligand are also
smaller for the co-ordinated compared to the free oxygen
atoms: O(1)]C(11)]C(12) 114.1(5), O(2)]C(12)]C(11) 115.9(5);
O(4)]C(11)]C(12) 121.4(6), O(3)]C(12)]C(11) 120.0(6)8. This
is in contrast to complex 1 in which the oxalate is co-ordinated
on both sides to ruthenium atoms, giving rise to the equivalence
of all four C]O bonds [1.256(5) Å] and of all four O]C]C
angles [117.2(4)8].
The dinuclear cation [Ru2(m-h4-C2O4)(MeOH)2(h6-p-PriC6-
Fig. 2 View of the structure of [Ru(h2-C2O4)(PPh3)(h6-p-PriC6H4Me)]
4
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H4Me)2]21 5 was obtained by using Ag1 to remove the chloride
ligands of 1 in methanolic solution (Scheme 2) and isolated
as the triflate (O3SCF3) salt. The IR spectrum of 5 displays
only one strong absorption at 1631 cm21 for the co-ordinated
oxalate. In the 1H NMR spectrum the methanol ligands could
not be found in CD3OD. However, the co-ordination of meth-
anol was unambiguously revealed by a single-crystal X-ray
structural analysis of the CF3SO3 salt of 5 (Fig. 3). Complex 5
retains the conformation of 1, and there are no apparent
changes in bond lengths and angles except a slightly increased
angle of C(1)]O(1)]Ru(1) from 112.6(2) to 114.2(4)8. A slightly
increased Ru ? ? ? Ru distance in 5 [5.548(5) Å] is also found
compared to that in 1 [mean 5.503(6) Å] (Table 2).
Table 2 Selected bond lengths (Å) and angles (8) for compounds 4 and
5 
4 
Ru]P 
Ru]O(2) 
Ru]O(1) 
C(11)]O(4) 
C(11)]O(1) 
C(11)]C(12) 
C(12)]O(3) 
C(12)]O(2) 
 
O(2)]Ru]O(1) 
O(2)]Ru]P 
O(1)]Ru]P 
O(4)]C(11)]O(1) 
O(4)]C(11)]C(12) 
O(1)]C(11)]C(12) 
O(3)]C(12)]O(2) 
O(3)]C(12)]C(11) 
O(2)]C(12)]C(11) 
C(11)]O(1)]Ru 
C(12)]O(2)]Ru 
 
2.367(2) 
2.080(3) 
2.084(4) 
1.221(7) 
1.300(6) 
1.548(8) 
1.226(6) 
1.271(6) 
 
78.6(2) 
84.41(11) 
90.46(12) 
124.5(6) 
121.4(6) 
114.1(5) 
124.1(6) 
120.0(6) 
115.9(5) 
114.2(4) 
114.9(4) 
5
Ru(1)]O(3) 
Ru(1)]O(1) 
Ru(1)]O(2a) 
C(1)]O(2) 
C(1)]O(1) 
C(1)]C(1a) 
O(3)]C(13) 
Ru ? ? ? Ru 
 
O(3)]Ru(1)]O(1) 
O(3)]Ru(1)]O(2a) 
O(1)]Ru(1)]O(2a) 
O(2)]C(1)]O(1) 
O(2)]C(1)]C(1a) 
O(1)]C(1)]C(1a) 
C(1)]O(1)]Ru(1) 
C(1)]O(2)]Ru(1a) 
C(13)]O(3)]Ru(1) 
 
 
 
2.104(5) 
2.120(4) 
2.130(4) 
1.258(7) 
1.260(7) 
1.519(14) 
1.348(10) 
5.548(5) 
 
82.2(2) 
83.5(2) 
77.8(2) 
125.7(6) 
117.4(6) 
116.9(7) 
114.2(4) 
113.6(4) 
130.3(6) 
 
 
Symmetry operation: a 2x, 2y 1 2, 2z 1 2. 
The reaction of the methanol complex 5 with 4,49-bipyridine
gave the macrocyclic cation [Ru4(m-h4-C2O4)2(m-h1 :h1-bipy)2-
(h6-p-PriC6H4Me)4]41 6 (Scheme 2). The IR spectrum exhibits
only one nCO band at 1636 cm
21, and the 1H NMR spectrum
indicates a symmetrical structure with 4,49-bipyridine as a
bridging ligand. The single-crystal X-ray analysis of the
CF3SO3 salt reveals a macrocycle with alternating oxalato and
4,49-bipyridine bridges between the ruthenium atoms as shown
in Fig. 4. The complex possesses crystallographic C2 symmetry,
hence the two oxalato planes are parallel to one another. The
two pyridine rings of each 4,49-bipyridine ligand are not
coplanar, being inclined to one another by an angle of 19.5(7)8.
The dihedral angles between the two rings of bipyridine and the
oxalato planes are 86.3(4) [a∧d] and 83.0(3)8 [a∧c], respectively
(Table 3). The macrocyclic arrangement of 6 is responsible for
the distortion of the (h6-p-PriC6H4Me)Ru(m-h
4-C2O4)Ru(h
6-p-
PriC6H4Me) units with respect to complex 5. In 6 the two Ru]O
bonds on the same side of the oxalato ligand are inequivalent
[Ru(1)]O(4) 2.098(9), Ru(1)]O(3) 2.134(9); Ru(2)]O(1)
2.141(9), Ru(2)]O(2) 2.101(9) Å]. Other important bond
lengths, angles and dihedral angles are summarized in Table 3.
The poor quality of the crystal and the problems of disorder of
Fig. 3 View of the structure of [Ru2(m-h4-C2O4)(MeOH)2(h6-p-Pri-
C6H4Me)2]21 5 (anions omitted for clarity)
3
Fig. 4 View of the structure of [Ru4(m-h4-C2O4)2(m-h1 :h1-bipy)2(h6-p-PriC6H4Me)4]41 6 (anions omitted for clarity)
the anion in 6 give rise to considerable errors in the bond
lengths and angles.
In an attempt to replace the chloride ligands in 1 by azido
ligands the complex was treated with sodium azide in a
chloroform–methanol solution. However, in this case the bridg-
ing oxalato ligand was displaced, giving rise to the known
complex [{Ru(m-h1-N3)Cl(h6-p-PriC6H4Me)}2] 7 (Scheme 2).
This compound had already been synthesized and structurally
characterized by Wright and co-workers 22 from the reaction of
[{RuCl2(h6-p-PriC6H4Me)}2] with SiMe3N3.
Experimental
All synthetic operations were performed in a nitrogen atmos-
phere using standard Schlenk techniques. Organic solvents were
dried over appropriate drying agents, then distilled and kept
Table 3 Selected bond lengths (Å) angles (8) and dihedral angles* (8)
for compound 6
Ru(1)]O(3) 
Ru(2)]O(1) 
Ru(1)]N(1) 
C(1)]O(2) 
C(1)]O(4) 
C(1)]C(2) 
N(1)]C(27) 
N(2)]C(32) 
Ru ? ? ? Ru
(bipy bridged) 
 
O(4)]Ru(1)]N(1) 
N(1)]Ru(1)]O(3) 
O(2)]Ru(2)]O(1) 
O(4)]C(1)]O(2) 
O(2)]C(1)]C(2) 
O(1)]C(2)]C(1) 
C(27)]N(1)]C(23) 
C(23)]N(1)]Ru(1) 
C(32)]N(2)]Ru(2) 
 
a∧d(f∧b) 
c∧d(e∧f) 
d∧f  
2.134(9) 
2.141(9) 
2.117(10) 
1.251(15) 
1.248(15) 
1.544(18) 
1.322(19) 
1.322(18) 
11.315(10)
 
84.7(4) 
83.9(4) 
77.8(3) 
126.8(13) 
115.9(14) 
117.5(14) 
118.0(12) 
120.3(10) 
121.7(10) 
 
86.3(4) 
46.3(5) 
65.5(4) 
Ru(1)]O(4) 
Ru(2)]O(2) 
Ru(2)]N(2) 
C(2)]O(1) 
C(2)]O(3) 
N(1)]C(23) 
N(2)]C(28) 
Ru ? ? ? Ru 
(oxalato bridged) 
 
O(4)]Ru(1)]O(3) 
O(2)]Ru(2)]N(2) 
N(2)]Ru(2)]O(1) 
O(4)]C(1)]C(2) 
O(1)]C(2)]O(3) 
O(3)]C(2)]C(1) 
C(27)]N(1)]Ru(1) 
C(32)]N(2)]C(28) 
C(28)]N(2)]Ru(2) 
 
a∧c(b∧e) 
c∧f(d∧e) 
c∧e 
2.098(9) 
2.101(9) 
2.136(10) 
1.245(15) 
1.271(16) 
1.340(19) 
1.352(18) 
5.532(9)
 
 
78.1(3) 
87.6(4) 
84.6(4) 
117.1(14) 
126.6(13) 
115.9(13) 
121.6(10) 
116.3(12) 
122.6(11) 
 
83.0(4) 
19.5(7) 
26.9(4) 
* See Fig. 4 for a–f. 
under inert gas before use. The starting material [{RuCl2(h6-p-
PriC6H4Me)}2] was prepared according to the literature
method.19 All other reagents were commercially available and
used as received.
The NMR spectra were recorded on Varian Gemini 200 and
Bruker AMX 400 instruments with SiMe4 as internal standard
in organic solvents and sodium 4,4-dimethyl-4-silapentane-1-
sulfonate as internal standard in D2O. Chemical shifts for 
31P
resonances were referred to 85% H3PO4. Infrared spectra were
recorded as KBr pellets on a Perkin-Elmer FTIR 1720 X
spectrometer. Microanalytical data were obtained from the
Mikroelementar-analytisches Laboratorium der ETH Zürich,
and mass spectra (FAB) from Professor Titus A. Jenny,
University of Fribourg.
Preparation
[Ru2(ì-ç
4-C2O4)Cl2(ç
6-p-PriC6H4Me)2] 1. To a solution of
[{RuCl2(h6-p-PriC6H4Me)}2] (306 mg, 0.5 mmol) in CHCl3–
MeOH (1 :1, 30 cm3) was added (NH4)2C2O4?H2O (71 mg, 0.5
mmol). The mixture was refluxed for about 6 h, then the solvent
was removed. The residue was taken up in CH2Cl2 and the
resulting slurry filtered to remove the salts. The filtrate was
evaporated to dryness in vacuo to give compound 1 as an
orange powder. Yield 280 mg (89%). Crystals suitable for
X-ray analysis were obtained by slow evaporation of a CHCl3
solution (Found: C, 42.15; H, 4.43. C22H28Cl2O4Ru2 requires
C, 41.97; H, 4.48%). IR (cm21): n(CO) 1614vs. 1H NMR
(CDCl3): d 5.569 (2 H, d, J = 6.4, C6H4), 5.336 (2 H, d,
J = 6.4 Hz, C6H4), 2.883 [1 H, m, CH(CH3)2], 2.229 (3 H, s,
CH3), 1.333 [3 H, s, CH(CH3)2] and 1.298 [3 H, s, CH(CH3)2].
13C NMR (CDCl3): d 171.2 (CO), 99.8, 95.5, 80.4, 78.4
(C6H4), 31.1 [CH(CH3)2], 22.4 [CH(CH3)2] and 18.5 (CH3).
FAB mass spectrum: m/z (%) (18, M1), (50, [M 2 Cl]1) and
(60, [M 2 C2O4]1).
[Ru(ç2-C2O4)(NH3)(ç
6-p-PriC6H4Me)] 2. To a suspension of
[{RuCl2(h6-p-PriC6H4Me)}2] (122 mg, 0.2 mmol) in water (15
cm3) was added Ag2SO4 (125 mg, 0.4 mmol). The mixture was
stirred at room temperature for 3 h, then filtered. The salt
(NH4)2C2O4?H2O (57 mg, 0.4 mmol) was added to the filtrate,
then the pH was adjusted to 7–8 and temperature raised to
70 8C for 1–2 h. The solvent was evaporated to dryness and
addition of CH2Cl2 gave a slurry which was filtered to remove
4
the salts. The filtrate was evaporated in vacuo to give compound
2 as a yellow powder. Yield 120 mg (84%). Recrystallization
from methanol–diethyl ether afforded yellow crystals (Found:
C, 39.80; H, 5.13; N, 4.11. C12H17NO4Ru?H2O requires C,
40.22; H, 5.30; N, 3.91%). IR (cm21): n(CO) 1665vs, 1701(br) s;
n(NH) and n(OH) 3177–3300w. 1H NMR (CD3OD): d 5.725
(2 H, d, J = 6.2, C6H4), 5.478 (2 H, d, J = 6.2 Hz, C6H4), 2.848 [1
H, m, CH(CH3)2], 2.214 (3 H, s, CH3), 1.351 [3 H, s, CH(CH3)2]
and 1.317 [3 H, s, CH(CH3)2]. 13C NMR (CD3OD); d 167.9
(CO), 101.6, 97.5, 83.1, 80.5 (C6H4), 32.3 [CH(CH3)2], 22.9
[CH(CH3)2] and 18.2 (CH3). FAB mass spectrum: m/z (%) (10,
[M 2 H2O]1), (12, [M 2 H2O 2 NH3]1), (70, [M 2 H2O 2
C2O4]1) and (35, [M 2 H2O 2 NH3 2 C2O4]1).
[Ru2(ì-ç
4-C2O4)(PPh3)2(ç
6-p-PriC6H4Me)2][O3SCF3]2 3. To a
solution of compound 1 (63 mg, 0.1 mmol) in CHCl3–MeOH
(1 :1, 20 cm3) were added solid PPh3 (52.8 mg, 0.2 mmol) and
Na[O3SCF3] (42 mg, 0.24 mmol). The mixture was stirred at
40 8C for 36 h. Then the solvent was drawn off, and the
orange residue taken up in CH2Cl2. The slurry was centri-
fuged to remove the insoluble materials. The resulting solu-
tion was then treated with ether in order to precipitate the
product. The supernatant was discarded and the yellow pow-
der was washed with ether and then dried in vacuo. Yield 110
mg (80%) (Found: C, 52.41; H, 4.35. C60H58F6O10P2Ru2S2
requires C, 52.17; H, 4.23%). IR (cm21): n(CO) 1626vs. 1H
NMR (CDCl3): d 7.883–7.301 (30 H, m, PPh3), 5.200 (2 H, d,
J = 6.0, C6H4), 4.992 (2 H, d, J = 6.0 Hz, C6H4), 2.854 [1 H,
m, CH(CH3)2], 1.872 (3 H, s, CH3), 1.121 [3 H, s, CH(CH3)2]
and 1.086 [3 H, s, CH(CH3)2]. 31P NMR (CDCl3): d 32.1.
FAB mass spectrum: m/z (%) {100, [Ru(PPh3)(h6-p-
PriC6H4Me)]1} and {80, [Ru(PPh3)]1}.
[Ru(ç2-C2O4)(PPh3)(ç
6-p-PriC6H4Me)] 4. Solid PPh3 (52.8
mg, 0.2 mmol) was added to a solution of compound 2 in
CHCl3–MeOH (1 :1, 20 cm
3). The mixture was stirred at 40 8C
for 30 h, and then concentrated to a smaller volume (about 2
cm3). Ether was added to precipitate the product. The yellow
powder was isolated by decanting and washed with ether, then
dried in vacuo. Yield 95 mg (81%). Crystals suitable for the
X-ray analysis were grown by slow diffusion of hexane into a
CHCl3 solution of 4 (Found: C, 52.52; H, 4.26. C30H29O4PRu?
CHCl3 requires C, 52.75; H, 4.25%). IR (cm
21): n(CO) 1694vs
and 1672vs. 1H NMR (CDCl3): d 7.537–7.343 (15 H, m, PPh3),
5.324 (2 H, d, J = 5.8, C6H4), 5.091 (2 H, d, J = 5.8 Hz, C6H4),
2.531 [1 H, m, CH(CH3)2], 1.908 (3 H, s, CH3), 1.159 [3 H, s,
CH(CH3)2] and 1.124 [3 H, s, CH(CH3)2]. 31P NMR (CDCl3):
d 30.4. FAB mass spectrum: m/z (%) (33, M1), (100,
[M 2 C2O4]1), {87, [M 2 (h6-p-PriC6H4Me) 2 C2O4]1} and (30,
[M 2 PPh3 2 C2O4]1).
[Ru2(ì-ç
4-C2O4)(MeOH)2(ç
6-p-PriC6H4Me)2][O3SCF3]2 5.
Solid Ag[O3SCF3] (102.8 mg, 0.40 mmol) was added to a solu-
tion of compound 1 (126 mg, 0.2 mmol) in methanol (20 cm3).
The mixture was stirred at room temperature for 2 h, then
filtered. The filtrate was evaporated to dryness to give 5 as a
yellow solid. Yield 184 mg (100%). Recrystallization from
methanol–ether gave well shaped orange crystals (Found: C,
33.79; H, 3.85. C26H36O12F6Ru2S2 requires C, 33.91; H, 3.94%).
IR (cm21): n(CO) 1631vs. 1H NMR (CD3OD): d 5.978 (2 H, d,
J = 6.2, C6H4), 5.772 (2 H, d, J = 6.2 Hz, C6H4), 2.888 [1 H, m,
CH(CH3)2], 2.271 (3 H, s, CH3), 1.399 [3 H, s, CH(CH3)2]
and 1.366 [3 H, s, CH(CH3)2]. FAB mass spectrum: m/z (%)
(100, [M 2 2MeOH 2 O3SCF3]1) and (8, [M 2 2MeOH 2
2O3SCF3]1).
[Ru4(ì-ç
4-C2O4)2(ì-ç
1 :ç1-bipy)2(ç
6-p-PriC6H4Me)4][O3SCF3]4
6. Solid 4,49-bipyridine (31.2 mg, 0.2 mmol) was added to a
solution of compound 5 (184 mg, 0.2 mmol) in methanol (20
cm3). The mixture was stirred at room temperature for 24 h,
then reduced to dryness, yielding 6 as an orange-red solid (203
mg, 100%). Suitable crystals for X-ray analysis were grown by
slow diffusion of ether into an acetonitrile solution (Found: C,
40.05; H, 3.41; N, 3.02. C68H72F12N4O20Ru4S4 requires C, 40.32;
H, 3.58; N, 2.77%). IR (cm21): n(CO) 1636vs. 1H NMR
[(CD3)2CO]: d 8.286 (4 H, d, J = 6.6, 4,49-bipy), 7.900 (4 H, d,
J = 6.6, 4,49-bipy), 6.094 (2 H, d, J = 6.6, C6H4), 5.932 (2 H, d,
J = 6.6 Hz, C6H4), 2.910 [1 H, m, CH(CH3)2], 2.234 (3 H, s,
CH3), 1.377 [3 H, s, CH(CH3)2] and 1.342 [3 H, s, CH(CH3)2].
FAB mass spectrum: m/z (%) (12, [¹¯
²
M 2 O3SCF3]1), (100,
[¹¯
²
M 2 bipy 2 O3SCF3]1) and (8, [¹¯²M 2 bipy 2 2O3SCF3]
1).
[{Ru(ì-ç1-N3)Cl(ç
6-p-PriC6H4Me)}2] 7. To a solution of com-
pound 1 (63 mg, 0.1 mmol) in CHCl3–MeOH (1 :1, 20 cm
3) was
added solid NaN3 (13 mg, 0.2 mmol). The mixture was stirred
at room temperature for 14 h, then evaporated to dryness. The
orange residue was treated with CH2Cl2 to give a slurry which
was filtered. The resulting filtrate was concentrated to a smaller
volume (5 cm3), then methanol and ether were added for crys-
tallization. Yield 43 mg (70%). n(NN) 2059s cm21. 1H NMR
(CDCl3): d 5.333 (2 H, d, J = 6.2, C6H4), 5.247 (2 H, d,
J = 6.2 Hz, C6H4), 2.907 [1 H, m, CH(CH3)2], 2.258 (3 H, s,
CH3), 1.291 [3 H, s, CH(CH3)2] and 1.269 [3 H, s, CH(CH3)2].
Crystallography
Orange crystals of compounds 1a, 1b and 4–6 were glued on the
top of a glass fibre and mounted on a Stoe-Siemens AED2
four-circle diffractometer. Intensity data were measured using
graphite-monochromated Mo-Ka radiation (l = 0.710 73 Å).
Compounds 1a, 4 and 6 were measured at room temperature
while data for 1b and 5 were collected at 250 8C. The w–2q
scan technique was used to a maximum 2q value of 51.08.
The cell parameters were determined from a least-squares
treatment of the setting angles of 20 reflections with
12.5 < q < 18.48 (1a), 20 with 12.5 < q < 20.08 (1b), 22
with 12.5 < q < 17.28 (4), 22 with 14.0 < q < 19.28 (5) and 18
with 14.0 < q < 17.28 (6). For each compound the intensities of
two representative reflections were measured every 60 min. Dur-
ing data collection the intensity of the standards decreased by
less than 1% for all the compounds. Table 4 provides summaries
of the crystal data, data collection and refinement parameters.
No absorption corrections were applied, as the m(Mo-Ka)
values were all less than 2.0 mm21. For 6 the crystals were very
irregular in shape and no suitable y scans were available.
The structures were solved by direct methods using the pro-
gram SHELXS 86 23 and refined by full-matrix least squares on
F 2 with SHELXL 93.24 Hydrogen atoms were included in calcu-
lated positions and treated as riding atoms using SHELXL 93
default parameters. Crystals of compounds 5 and 6 could only
be obtained using CF3SO3
2 as counter ion. In the case of 6 only
poor-quality crystals with a large mosaic spread could be
obtained. In these the counter ions CF3SO3
2 were highly dis-
ordered. Three partially occupied positions were found (occu-
pancy 0.50 and 2 × 0.25) and it was necessary to apply con-
straints. A DFIX instruction was used to improve the C]F, C]S
and S]O distances.The isopropyl substituent of the p-cymene
ligand was also disordered in such a manner that one methyl
group occupied two positions with an occupancy of 0.5. These
problems, together with the poor quality of the crystal and the
lack of absorption correction, are probably responsible for the
high R factors and the considerable errors in bond lengths and
angles for complex 6.
The figures were drawn with SCHAKAL.25
CCDC reference number 186/730.
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Table 4 Crystallographic data, data collection and refinement parameters for compounds 1a, 1b and 4–6
 
Formula 
M 
Crystal size/mm 
T/K 
Crystal system 
Space group 
a, b, c/Å
b/8 
U/Å3 
Z 
m(Mo-Ka)/mm21 
Dc/g cm
23 
F(000) 
q Scan range/8 
No. reflections measured 
No. independent reflections 
No. observed reflections 
Goodness of fit on F 2 
Final R1, wR2 indices
[I > 2s(I)] 
(all data) 
Drmax, Drmin/e Å
23 
1a 
C22H28Cl2O4Ru2 
629.48 
0.46 × 0.27 × 0.15 
293(2) 
Monoclinic 
P21/n 
7.571(1), 8.998(1),
16.528(2) 
95.52(1) 
1120.7(2) 
2 
1.163 
1.865 
628 
2.48–25.49 
2083 
2083 
1700 
1.185 
0.0407, 0.0954 
0.0520, 0.1108
1.444, 21.385 
1b 
C22H28Cl2O4Ru2 
629.48 
0.68 × 0.30 × 0.27 
223(2) 
Orthorhombic 
Pbca 
10.486(1), 11.822(1),
18.961(2) 
 
2350.5(4) 
4 
1.538 
1.779 
1256 
2.15–25.48 
2186 
2186 
1936 
1.221 
0.0292, 0.0714 
0.0359, 0.0779
0.453, 20.549 
4 
C30H29O4PRu 
585.57 
0.61 × 0.23 × 0.23 
293(2) 
Monoclinic 
P21/c 
8.705(1), 15.388(2),
19.727(3) 
90.16(1) 
2642.5(6) 
4 
0.688 
1.472 
1200 
2.06–25.52 
4931 
4931 
3695 
1.212 
0.0546, 0.0850 
0.0862, 0.1071
0.418, 20.350 
5 
C26H36F6O12Ru2S2 
920.8 
0.30 × 0.30 × 0.15 
223(2) 
Monoclinic 
P21/a 
11.066(1), 13.374(2),
11.441(1) 
95.94(1) 
1684.2(4) 
2 
1.112 
1.816 
924 
2.15–25.51 
3139 
3139
2527 
1.192 
0.0543, 0.1270 
0.0737, 0.1533
0.861, 20.535 
6 
C68H72F12N4O20Ru4S4 
2027.83 
0.61 × 0.38 × 0.11 
293(2) 
Monoclinic 
I2/a 
20.728(2), 14.606(5),
29.663(5) 
109.84(1) 
8448(3) 
4 
0.893 
1.594 
4072 
2.03–25.51 
7868 
7868 
4182 
1.163 
0.1088, 0.2065 
0.2010, 0.2619
1.0861, 20.535 
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